MAP1LC3A and Alzheimer disease: However, LC3 was decreased in temporal (padj = 0.036) and occipital (padj = 0.033) cortexes of DLB patients compared to those in AD patients, and in the temporal cortex of FTD patients compared to that in AD patients (padj = 0.041).